Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein e genotype

American Journal of Geriatric Psychiatry

Volumn 20, Issue 7, 2012, Pages 574-583

  Yasuno, Fumihiko ^a,b   Tanimukai, Satoshi ^a,d   Sasaki, Megumi ^a   Hidaka, Shin ^a   Ikejima, Chiaki ^a   Yamashita, Fumio ^a,c   Kodama, Chiine ^a   Mizukami, Katsuyoshi ^a   Michikawa, Makoto ^e   Asada, Takashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Apolipoprotein E; cognitive function; high density lipoprotein; low density lipoprotein; total cholesterol; triglyceride

Indexed keywords

APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; FEMALE; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE;

EID: 84863519953     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318211819b     Document Type: Article

References (33)

1. van Exel E, de Craen AJ, Gussekloo J, et al: Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 2002; 51:716-721 (Pubitemid 34568850)
2. Yaffe K, Barrett-Connor E, Lin F, et al: Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59:378-384 (Pubitemid 34208144)
3. Henderson VW, Guthrie JR, Dennerstein L: Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 2003; 74:1530-1535
4. Sabbagh M, Zahiri HR, Ceimo J, et al: Is there a characteristic lipid profile in Alzheimer's disease? J Alzheimers Dis 2004; 6:585-589 (Pubitemid 40164164)
5. Anstey KJ, Lipnicki DM, Low LF: Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008; 16: 343-354
6. Mahley RW, Rall SCJ: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537
7. Pablos-Ḿendez A, Mayeux R, Ngai C, et al: Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997; 17:3534-3541 (Pubitemid 28028566)
8. Lee BK, Glass TA, Wand GS, et al: Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry 2008; 165:1456-1464
9. Fillenbaum GG, Landerman LR, Blazer DG, et al: The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. J Am Geriatr Soc 2001; 49:1148-1155 (Pubitemid 32900140)
10. Small BJ, Rosnick CB, Fratiglioni L, et al: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19: 592-600 (Pubitemid 39603405)
11. West R, Beeri MS, Schmeidler J, et al: Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. Am J Geriatr Psychiatry 2008; 16:781-785
12. Miyamoto M, Kodama C, Kinoshita T, et al: Dementia and mild cognitive impairment among non-responders to a community survey. J Cli Neurosci 2009; 16:270-276
13. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
14. Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17:37-49 (Pubitemid 13123113)
15. Sohlberg M, Mateer CA: Attention process training manual., Washington, Association for neuropsychological research & development, 1986
16. Grober E, Buschke H, Crystal H, et al: Screening for dementia by memory testing. Neurology 1988; 38:900-903
17. Solomon PR, Pendlebury WW: Recognition of Alzheimer's disease: the 7 Minute Screen. Fam Med 1998; 30:265-271 (Pubitemid 28298008)
18. Wechsler D: WAIS-R : manual : Wechsler adult intelligence scale-revised., New York, Harcourt Brace Jovanovich for Psychological Corp, 1981
19. Zuliani G, Ble' A, Zanca R, et al: Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriatr 2001; 1:1-5 (Pubitemid 38870361)
20. Muckle TJ, Roy JR: High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet 1985; 1:1191-1193 (Pubitemid 15083674)
21. Breteler MM, van Swieten JC, Bots ML, et al: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44:1246-1252 (Pubitemid 24232223)
22. Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21:321-330 (Pubitemid 30387091)
23. Koudinov AR, Berezov TT, Kumar A, et al: Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 1998; 270:75-84 (Pubitemid 28095681)
24. Olesen OF, Dagø L: High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun 2000; 270:62-66 (Pubitemid 30440393)
25. Cockerill GW, Huehns TY, Weerasinghe A, et al: Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 2001; 103: 108-112 (Pubitemid 32050444)
26. Dietschy JM, Turley SD: Cholesterol metabolism in the brain. Curr Opin Lipidol 2001; 12:105-112 (Pubitemid 32242918)
27. Heeren J, Grewal T, Laatsch A, et al: Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J Biol Chem 2003; 278:14370-14378 (Pubitemid 36799988)
28. Heeren J, Beisiegel U, Grewal T: Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:442-448.
29. Davignon J, Cohn JS, Mabile L, et al: Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999; 286:115-143 (Pubitemid 29406104)
30. Tangirala RK, Pratićo D, FitzGerald GA, et al: Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 2001; 276:261-266 (Pubitemid 32050315)
31. Heeren J, Grewal T, Laatsch A, et al: Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem 2004; 279:55483-55492 (Pubitemid 40066549)
32. Huang Y, von Eckardstein A,Wu S, et al: Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J Clin Invest 1995; 96:2693-2701
33. Michikawa M, Fan QW, Isobe I, et al: Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem 2000; 74:1008-1016 (Pubitemid 30104296)